You are viewing: Latin America Long Read Sequencing Market analysis
Part of: Long Read Sequencing Market (Global)

The Latin America Long Read Sequencing Market was valued at $23.5 Million in 2024 and projected to reach to $86.8 Million by 2029, representing a compound annual growth rate of 29.9%. Latin America's long read sequencing market is positioned for substantial growth as healthcare systems modernize and embrace precision medicine frameworks.

Latin America Long Read Sequencing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Latin America Long Read Sequencing Market Trends and Insights

  • Latin America's adoption of advanced genomic technologies is accelerating as healthcare institutions and research centers invest in precision medicine capabilities.
  • The region's growth trajectory reflects increasing demand for long read sequencing applications in clinical diagnostics, infectious disease monitoring, and agricultural genomics across Latin America. Latin America's 29.9% compound annual growth rate significantly outpaces many mature markets, driven by rising healthcare expenditures and growing awareness of genomic medicine benefits.
  • In Latin America, key drivers include expanding laboratory infrastructure, government support for biotechnology initiatives, and partnerships with global sequencing providers.
  • By 2029, Latin America is expected to establish itself as a meaningful contributor to the global long read sequencing ecosystem, with emerging biotech hubs and academic institutions leading innovation adoption across the region..

Key Market Statistics

  • CAGR (2024-2029) 29.9% CAGR
  • Market Size, 2024 ~USD 23.5 Million
  • Forecast, 2029 ~USD 86.8 Million
  • Geography Latin America

Latin America Long Read Sequencing Market Overview

Rapid Market Expansion :

Latin America's long read sequencing market is growing at 29.9% CAGR, expanding from $23.5 million in 2024 to $86.8 million by 2029, driven by increased adoption of precision medicine and genomic research capabilities across the region.

Brazil's Market Leadership :

Brazil dominates Latin America's long read sequencing market with $41.5 million in market size, representing the largest healthcare investment in genomic technologies and serving as the regional hub for advanced sequencing adoption.

Healthcare Institution Investment :

Major research centers and healthcare institutions across Latin America are significantly investing in long read sequencing infrastructure to enhance diagnostic accuracy and support personalized medicine initiatives in oncology and rare disease detection.

Emerging Market Opportunities :

Mexico and Argentina are emerging as secondary growth markets with $17.3 million and $11.7 million respectively, presenting untapped opportunities for long read sequencing technology providers and genomic service providers.

Latin America Long Read Sequencing Market Dynamics

  • The region's investment in genomic infrastructure reflects a broader shift toward advanced diagnostic capabilities, with Brazil leading adoption while Mexico and Argentina accelerate their genomic research initiatives.
  • Government support for healthcare innovation and increasing collaboration with international research institutions are accelerating technology deployment across the region. The forecast period through 2029 will see intensified competition among sequencing platform providers and growing demand for bioinformatics expertise.
  • Latin American countries are establishing genomic centers of excellence and expanding clinical applications in cancer genomics and rare disease diagnosis.
  • Strategic partnerships between regional healthcare providers and global sequencing technology companies will further drive market penetration and localization of long read sequencing services..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • Latin America's long read sequencing market is valued at $23.5 million in 2024 and will grow to $86.8 million by 2029, representing a 29.9% CAGR.
    • Latin America is experiencing accelerated adoption of long read sequencing in clinical diagnostics, infectious disease surveillance, and agricultural applications.
    • Government biotechnology initiatives and institutional partnerships are driving infrastructure expansion and technology adoption across Latin America.
    • Latin America's emerging biotech ecosystem positions the region as a high-growth market with significant potential for innovation and market consolidation by 2029.

    Long Read Sequencing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment DATA ANALYSIS (Workflow)
    Forecast Period 2024-2029
    Growth Rate CAGR of 32.8% from 2024 to 2029
    Largest Segment RESEARCH USAGE (Usage)
    Market Size Base Year (Billions) ~USD 0.76 (2024)
    Revenue Forecast (Billions) ~USD 3.13 (2029)
    Segments Covered Offering, Technology, Workflow, Application, Usage, End User

    Latin America Long Read Sequencing Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Offering

    • Consumables
    • Instruments
    • Services

    By Technology

    • Nanopore Sequencing
    • Single-Molecule Real-Time Sequencing
    • Synthetic Long-Read Sequencing

    By Workflow

    • Data Analysis
    • Sample Preparation
    • Sequencing

    By Application

    • Epigenetics
    • Metagenomics
    • Other Applications
    • Targeted Sequencing
    • Whole-Exome Sequencing
    • Whole-Genome Sequencing

    By Usage

    • Clinical Usage
    • Research Usage

    By End User

    • Academic & Research Institute
    • Academic & Research Institutes
    • Hospitals, Clinics & Diagnostic
    • Hospitals, Clinics, And Diagnostic Labs
    • Other End User
    • Other End Users
    • Pharmaceutical & Biotechnologies Companies
    • Pharmaceutical & Biotechnology Companies
    • Pharmaceutical & Biotechnology Companies Labs

    Target Audience

    • Sequencing Technology Vendors : Manufacturers and distributors of long read sequencing platforms need Latin America market data to develop regional sales strategies, identify key healthcare institutions, and understand adoption barriers specific to emerging markets.
    • Healthcare Institutions & Hospitals : Hospital networks and diagnostic centers require market intelligence to benchmark their genomic capabilities against regional peers, justify capital investments in sequencing infrastructure, and plan precision medicine program expansion.
    • Genomic Research Organizations : Academic research centers and genomic institutes need regional market insights to secure funding, identify collaboration opportunities, and understand the competitive landscape for long read sequencing services and research applications.
    • Healthcare Investment Firms : Private equity and venture capital investors targeting Latin America's healthcare sector require detailed market sizing and growth forecasts to evaluate investment opportunities in genomic technology companies and diagnostic service providers.
    • Bioinformatics & Software Providers : Companies offering data analysis and bioinformatics solutions need Latin America market data to identify demand for complementary services, understand regional computational infrastructure gaps, and develop localized software offerings.

    Latin America vs. other regions

    HowLatin America compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 779 Million · 33.1% wtd CAGR ·
    Europe
    ~USD 526.3 Million · 33.7% wtd CAGR ·
    Asia Pacific
    ~USD 450.4 Million · 34.9% wtd CAGR ·
    Middle East
    ~USD 73.3 Million · 27.6% wtd CAGR ·

    Countries within Latin America - compare and drill down

    Country2025 size (native)
    BrazilUSD 41.5 Million
    MexicoUSD 17.3 Million
    ArgentinaUSD 11.7 Million
    Rest Of Latin AmericaUSD 16.2 Million

    Country market size visualization

    Brazil
    USD 41.5 Million
    Mexico
    USD 17.3 Million
    Argentina
    USD 11.7 Million
    Rest Of Latin America
    USD 16.2 Million

    Reasons to Buy this Report

    • Regional Market Segmentation : Gain detailed insights into Latin America's long read sequencing market with country-level breakdowns for Brazil, Mexico, and Argentina, enabling targeted market entry and expansion strategies specific to regional healthcare dynamics.
    • Growth Trajectory Analysis : Understand the 29.9% CAGR growth drivers and forecast projections through 2029, allowing stakeholders to identify optimal investment timing and resource allocation for long read sequencing infrastructure development.
    • Competitive Landscape Intelligence : Access comprehensive analysis of market consolidation trends, key players, and emerging competitors in Latin America's genomic sequencing sector to inform strategic positioning and partnership opportunities.
    • Healthcare Institution Insights : Identify investment patterns and technology adoption rates among Latin American research centers and hospitals, enabling vendors to tailor solutions and sales strategies to regional healthcare procurement processes.
    • Precision Medicine Opportunity Assessment : Evaluate the expanding precision medicine applications and clinical use cases driving long read sequencing adoption across Latin America's oncology, rare disease, and infectious disease diagnostic segments.

    Frequently asked questions

    What is the current market size of long read sequencing in Latin America?

    The long read sequencing market in Latin America was valued at $23.5 million in 2024 and is projected to reach $86.8 million by 2029.

    What is the expected growth rate for long read sequencing in Latin America?

    Latin America's long read sequencing market is expected to grow at a compound annual growth rate (CAGR) of 29.9% from 2024 to 2029.

    Which applications are driving long read sequencing adoption in Latin America?

    Key applications driving adoption in Latin America include clinical diagnostics, infectious disease monitoring, cancer genomics, and agricultural genomics applications.

    What factors are accelerating long read sequencing market growth in Latin America?

    Growth in Latin America is driven by increasing healthcare investments, government biotechnology support, expanding laboratory infrastructure, and rising precision medicine awareness.

    How does Latin America's growth compare to the global long read sequencing market?

    Latin America's 29.9% CAGR exceeds the global market CAGR of 32.8%, positioning the region as a high-growth emerging market with strong relative momentum.

    RESEARCH METHODOLOGY

    This study on the long-read sequencing market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the long-read sequencing market using several research strategies, the size of the final market was obtained by triangulating data from primary research.

    Secondary Research

    The secondary sources referred to for this research study include publications from government sources. These include Nucleic Acids Research, Genome Biology, Nature Reviews Genetics, Nature Methods, Genome Research, International Journal of Genomics, National Human Genome Research Institute (NHGRI), International Chromosome and Genome Society (ICGS), Genome Canada, European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), Organisation for Economic Co-operation and Development (OECD), Population Health Research Institute (PHRI),  PubMed, World Bank, and the World Health Organization (WHO), among others. Secondary sources also included corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global long-read sequencing market, which was validated through primary research.

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global long-read sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing long-read sequencing; experts from the demand side, such as personnel from academic & research institutes, hospitals, clinics and diagnostic labs, pharmaceutical & biopharmaceutical industries. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    The following is a breakdown of the primary respondents:

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the long-read sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Bottom-up Approach

    • The key players in the industry and market have been identified through extensive secondary research.
    • The revenues generated from the long-read sequencing market business of leading players have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Top-down Approach

    After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

    Long Read Sequencing Market Size, and Share

    Data Triangulation

    To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Long-read sequencing is a type of nucleic acid sequencing that produces genomic data by generating individual reads from single molecules, generally ranging in size from 700 to over 20,000 bases. These fragments are typically derived from "native" molecules, which are directly extracted from biological samples for analysis. The long-read sequencing market encompasses the consumables, instruments, services, and technology associated with long-read sequencing. The long-read sequencing market is defined as solutions including instruments/systems, consumables (kits, reagents, flow cells), and services for long-read sample preparation, sequencing, and data analysis. Long-read software solutions are often provided alongside the instrument/system/platform, hence the software solutions are considered within the instrument segment scope. Other standalone software solutions are provided as data analysis services and are considered within the services segment scope.

    Stakeholders

    • Academic & Research Institutes
    • Software & Bioinformatics Companies
    • Healthcare & Clinical Laboratories
    • Long-Read Sequencing Technology Vendors
    • Contract Research Organizations (CROs)
    • Market Research and Consulting Firms
    • Pharmaceutical & Biotechnology Companies
    • Regulatory Agencies
    • Venture Capitalists
    • Government Organizations
    • Industry Associations and Professional Societies

    Report Objectives

    • To define, describe, and forecast the long-read sequencing market based on offerings, technology, workflow, application, usage, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall long-read sequencing market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global long-read sequencing market and comprehensively analyze their instruments, consumables, and services portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product & service launches, expansions, agreements, and collaborations in the long-read sequencing market
    • To benchmark players within the long-read sequencing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Geographical Analysis

    • Further breakdown of the Rest of Europe Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Asia Pacific Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Latin America Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Middle East Long-Read Sequencing Market, by country

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Segment Analysis

    • Further breakdown of the other application and other end users area into subsegments
    • Cross-segment analysis

    Get the Full Long Read Sequencing Market Report

    Full forecast, segment splits, and company analysis for all Long Read Sequencing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status